Plant-Based Biopharmaceuticals

Plant-Based Biopharmaceuticals represent an innovative frontier in biotechnology, leveraging plants as biofactories for the production of therapeutic proteins and pharmaceuticals. This approach involves genetically engineering plants to express specific genes that encode for therapeutic proteins, enabling cost-effective and scalable production. It has the ability to produce complex proteins in a plant-based system, offering a flexible and sustainable alternative to traditional expression platforms. Plants such as tobacco, potatoes, and tomatoes are commonly used for this purpose. The process involves transforming plant cells with the desired gene, allowing them to produce the therapeutic protein. After cultivation, the harvested plants or plant cells serve as biofactories for the production of pharmaceuticals. This approach has shown promise for producing vaccines, antibodies, and other biologics.

Plant-Based Biopharmaceuticals offer benefits such as rapid scalability, reduced production costs, and potentially safer and more accessible production facilities. Additionally, plant-based systems contribute to the development of sustainable and environmentally friendly biomanufacturing practices. As research in this field advances, Plant-Based Biopharmaceuticals hold significant potential to transform the landscape of pharmaceutical production.